Track topics on Twitter Track topics that are important to you
Eleven Biotherapeutics is rebranding itself as Sesen Bio and investors are pleased. This morning shares of Eleven are up more than 4 percent in premarket trading.
Shares of newly dubbed Sesen Bio (formerly Eleven Biotherapeutics) have plunged 23 percent after the company released positive, three-month data from its ongoing Phase III high-grade non-muscle invasi...
We have published hundreds of Sesen Bio, Inc. news stories on BioPortfolio along with dozens of Sesen Bio, Inc. Clinical Trials and PubMed Articles about Sesen Bio, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Sesen Bio, Inc. Companies in our database. You can also find out about relevant Sesen Bio, Inc. Drugs and Medications on this site too.